Castaman G, Rodeghiero F, Lattuada A, La Greca G, Mannucci P M
Department of Hematology and Hemophilia, San Bortolo Hospital, Vicenza, Italy.
Am J Hematol. 1993 Dec;44(4):266-9. doi: 10.1002/ajh.2830440409.
Several studies have reported increased von Willebrand factor (vWF) levels in plasma of uremic patients, with a normal multimeric pattern. Two recent studies, however, have shown a reduction of the larger multimers of plasma vWF and one has also found low levels of platelet vWF in uremic patients with prolonged bleeding time (BT). We have measured plasma and platelet vWF and analyzed its multimeric pattern in 20 uremic patients, 11 with a prolonged BT and 9 with a normal BT. For Plasma vWF, no difference for vWF:Ag, RiCof, and ristocetin-induced platelet agglutination was found between the two groups with normal and prolonged BT. The multimeric pattern of plasma vWF, as evaluated by densitometric scanning of the electrophoretic gels, was normal in both groups. For platelet vWF, vWF:Ag and RiCof content was similar in the two groups. The multimeric pattern was indistinguishable from that of normal platelets. In conclusion, our study does not confirm the presence of a structural defect of plasma vWF and the reduction of platelet vWF content in uremia.
多项研究报道,尿毒症患者血浆中血管性血友病因子(vWF)水平升高,且多聚体模式正常。然而,最近两项研究显示血浆vWF的较大多聚体减少,还有一项研究发现出血时间(BT)延长的尿毒症患者血小板vWF水平较低。我们检测了20例尿毒症患者的血浆和血小板vWF,并分析了其多聚体模式,其中11例BT延长,9例BT正常。对于血浆vWF,BT正常组和延长组在vWF:Ag、瑞斯托霉素辅因子(RiCof)以及瑞斯托霉素诱导的血小板凝集方面未发现差异。通过对电泳凝胶进行光密度扫描评估,两组血浆vWF的多聚体模式均正常。对于血小板vWF,两组的vWF:Ag和RiCof含量相似。多聚体模式与正常血小板无法区分。总之,我们的研究未证实尿毒症患者血浆vWF存在结构缺陷以及血小板vWF含量降低。